Abbott Laboratories is buying Visiogen, a privately held ophthalmic device...

Abbott Laboratories is buying Visiogen, a privately held ophthalmic device company based in California. The $400 million deal should close during the fourth quarter. Abbott, based in Illinois, bought Advanced Medical Optics earlier this year. Visiogen markets the Synchrony intraocular lens for presbyopia in cataract patients; it has been available ...

To continue reading this article subscribe now

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

To continue reading this article register now.